http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108614052-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-8679 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-86 |
filingDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108614052-B |
titleOfInvention | Method for simultaneously detecting gelsemine, gelsemine and gelsemine in biological sample based on two-dimensional liquid chromatography |
abstract | The invention discloses a method for simultaneously detecting gelsemine, gelsemine and gelsemine in a biological sample based on two-dimensional liquid chromatography, which comprises the following steps: 1) pretreating a biological sample to obtain a solution to be detected; 2) a solution to be detected is injected into a 2D-LC-UV system for detection; 3) and carrying out quantitative analysis on the detection result. The method has the advantages of simple sample pretreatment, higher detection sensitivity than that of a common chromatogram, capability of effectively eliminating false positive, high instrument stability and the like, is suitable for qualitative and quantitative detection of gelsemine, gelsemine and gelsemine in various biological samples (blood, urine and muscle), and is also suitable for detection of in vitro samples and suspicious physical evidence. |
priorityDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.